Literature DB >> 27076258

Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.

Azusa Ogita1, Shin-Ichi Ansai2, Noriyuki Misago3, Takashi Anan4, Takaya Fukumoto4, Hidehisa Saeki5.   

Abstract

Keratoacanthoma (KA) is a unique and distinct clinicopathological entity, although there is often confusion regarding its differentiation from other types of crateriform tumors. In this study, the clinicopathological features of 380 epidermal crateriform tumors with a central keratin plug were re-examined and the tumors were histologically classified into seven types: (i) crateriform verruca; (ii) crateriform seborrheic keratosis; (iii) KA; (iv) KA with a conventional squamous cell carcinoma (SCC) component (KA-like SCC and KA with malignant transformation); (v) crateriform Bowen's disease; (vi) crateriform SCC arising from solar keratosis; and (vii) crater form of infundibular SCC. Our study proved that incidence of SCC developing in KA lesions was 17.4%. The incidence rate differed depending on a patient's ages: 8.3% in patients less than 70 years of age and 24.3% in those aged 70 years and older. Nearly all of the malignant crateriform neoplasms (94.7%) occurred on sun-exposed areas. Lesions on the face included 138 KA (59.5%), 65 malignant crateriform neoplasms (28%) and 29 benign crateriform neoplasms (12.5%). We conclude that KA is not a variant of SCC, but a benign and frequently regressing proliferative lesion or borderline neoplasm, although there is the potential for SCC to arise within KA. Because the incidence of SCC developed in KA lesions and the incidence of other malignant crateriform neoplasms are higher in patients aged 70 years and older, KA-like lesions on sun-exposed areas over 70 should be assessed carefully in consideration of the potential risk of malignancy.
© 2016 Japanese Dermatological Association.

Entities:  

Keywords:  crateriform verruca; infundibular squamous cell carcinoma; keratoacanthoma; keratoacanthoma with malignant transformation; keratoacanthoma-like squamous cell carcinoma

Mesh:

Year:  2016        PMID: 27076258     DOI: 10.1111/1346-8138.13390

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  3 in total

1.  Patterns of LC3A Autophagy Protein Expression in Keratoacanthomas.

Authors:  Efthimios Sivridis; Ioannis M Koukourakis; Stella Arelaki; Kostantina Balaska; Antonios Karpouzis; Alexandra Giatromanolaki
Journal:  Head Neck Pathol       Date:  2019-04-11

2.  Rapidly Growing and Aggressive Cutaneous Squamous Cell Carcinomas in a Patient Treated with Ruxolitinib.

Authors:  Álvaro March-Rodriguez; Beatriz Bellosillo; Alberto Álvarez-Larrán; Carles Besses; Ramon M Pujol; Agustí Toll
Journal:  Ann Dermatol       Date:  2019-02-28       Impact factor: 1.444

3.  Digital dermatoscopy as a useful tool for evaluating therapeutic efficacy in a patient with eruptive keratoacanthomas.

Authors:  Ruzica Jurakic Toncic; Sandra Jerkovic Gulin; Jaka Rados; Daska Stulhofer Buzina; Kresimir Kostovic; Giuseppe Argenziano
Journal:  Dermatol Pract Concept       Date:  2018-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.